Cardicomm Solutions, Inc. Press Releases

GEMS™ WIN Software and HeartCheck™ Sales Will Have Expanded Access into the United States Air Force and Other Military Establishments Toronto, Canada – CardioComm Solutions, Inc. (TSX-V:EKG) (“CardioComm Solutions” or the “Company”),CardioComm Solutions today announced that it has become an approved vendor for the sale of their HeartCheck™ products and ECG-based software solutions into numerous organizations within the umbrella of...

CIHR, Industry and Heart and Stroke funded study will start with in-pharmacy screening in October 2014 Toronto, Canada – CardioComm Solutions, Inc. (TSX-V:EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of electrocardiogram (“ECG”) acquisition and management software solutions, today announced it has completed its technology placement for the Canadian Stroke Prevention Intervention Network (“C-SPIN”)...

Screening efforts designed to increase awareness and provide education of the warning signs and implications of Atrial Fibrillation as a risk factor for stroke. TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) CardioComm Solutions and the Heart and Stroke Foundation are working together to implement the Company's SMART Monitoring based HeartCheck™ ECG screening solution at four trade shows in...

Custom Software Will Target the Growing Mobile Cardiac Telemetry (MCT) ECG Monitoring and Consumer Use Markets TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) confirmed today that they have executed a series of agreements involving a custom software development and royalty license with the newly formed and Toronto-based iMedical Innovations, Inc. ("IMED"). On September 15, 2014, the two...

ECG Modernization Project Links CardioComm Solutions to the FAA Aviation Medical Examiner (AME) Community TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) today confirmed that it has been listed as a cloud services provider under the launch of the Federal Aviation Administration (“FAA”) Civil Aerospace Medical Institute ECG Modernization project. The specific product involved is the...

Web-Presence will introduce the HeartCheck™ device to a global network of patients and affiliate organizations TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of electrocardiogram (“ECG”) acquisition and management software solutions, today announced an agency agreement with Arrhythmia Alliance based out of the United Kingdom.  The Arrhythmia...

Active sales and marketing efforts of GEMS™ WIN as a Windows 7 compatible ECG management software nets new license agreements from a wide array of customers TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) today announced that sales of its new Global ECG Management System release (GEMS™  WIN), a Windows 7 compatible version of the Company’s GEMS™ software technology, is...

Company Shifts Focus from R&D to Increased Resourcing of ECG Software Sales and Customer Support TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”), today announced operations and sales team changes intended to drive inside-sales through upgrading the Company's medical software customers to the new Windows 7 compatible Global ECG Management System software (GEMS™ WIN) and the Company's...

Web-based site provides access to the HeartCheck™ PEN by Canadians who are without easy access to pharmacies TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of electrocardiogram (“ECG”) acquisition and management software solutions, today announced a distribution agreement with Toronto-based PHARMACY.CA, for internet-based sales of the HeartCheck™...

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE: EKG) (“CardioComm Solutions” or the “Company”) announced today it had closed the first tranche of its previously announced private placement equity financing.  Under the closing of the first tranche, the Company issued 3,300,000 units at a price of $0.05 per unit, for gross proceeds of $165,000.  Each unit was comprised of one common share of the Company and one common share purchase...

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”), announced today it had closed the second tranche of its previously announced private placement equity financing. Under the closing of the second tranche, the Company issued 600,000 units at a price of $0.05 per unit, for gross proceeds of $30,000. Each unit was comprised of one common share of the Company and one common share purchase warrant...

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) today announced that it will be conducting a non-brokered private placement equity financing under which it intends to issue up to 5,000,000 units at a price of $0.05 per unit for gross proceeds of up to $250,000. There is no minimum offering amount. Each unit will be comprised of one common share of the Company and one common share purchase warrant...

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) today confirmed that its binding letter of intent with Vigilance, Inc., which was previously announced by the Company on June 16, 2014, has been terminated after several rounds of negotiations with the Vigilance Board of Directors failed in developing acceptable terms for entering into a definitive long term working relationship. “As...

Joint Venture will provide CardioComm Solutions with an equity position in Vigilance and recurrent licensing revenues TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) a global medical provider of electrocardiogram (“ECG”) acquisition and management software solutions has executed a binding Letter of Intent with Vigilance, Inc. to develop and co-market ECG contract service solution...

Company Remains on Track to Complete $1 Million in Financing in Q1 2014 TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) ("CardioComm Solutions" or the "Company")announced today it has closed the second tranche of its previously announced private placement equity financing. Under the financing, the Company issued 2,648,000 units at a price of $0.0675 per unit, for gross proceeds of $178,740. Each unit was comprised of one common share of the Company and one common...

HeartCheck™ Technologies to be used to identify people at risk for potentially life-threatening drug side effects TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of electrocardiogram ("ECG") acquisition and management software solutions, today announced it has entered into a partnership agreement with the Clinical Neuroendocrinology Laboratory at the University of...

Company Plans to Complete $1 Million in Financing in Q1 2014 TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) ("CardioComm Solutions" or the "Company") announced today it had closed the first tranche of its previously announced private placement equity financing. Under the financing, the Company issued $1,622,222 units at a price of $0.0675 per unit, for gross proceeds of $109,500. Each unit was comprised of one common share of the Company and one common share...

Clearance opens the way for HeartCheck™ Device Sales and SMART Monitoring ECG Services in China TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of electrocardiogram ("ECG") acquisition and management software solutions, confirms that China's Food and Drug Administration ("CFDA") has cleared the HeartCheck™ PEN ECG device and GEMS™ Home software for sale...

Completion of final milestone triggers a third payment and removal of non-completion penalties Toronto, Canada  – CardioComm Solutions, Inc. ( TSX-V:EKG) (“CardioComm Solutions” or the “Company”)today announced it has completed the final milestone of a software and source code licensing agreement ("SLA") for use of the Company's Global ECG Management Solution ("GEMS™") and GUAVA ECG viewer by MD Primer, Inc. ("MDP"), which was previously...

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) today announced that it has granted 250,000 incentive stock options to Etienne Grima, the Company’s CEO, in accordance with Mr. Grima’s employment agreement. The options are exercisable at $0.055 per share for five years from the date of grant, vest four months from the date of grant and are subject to a four month hold period. The grant...

CardioComm Solutions to begin immediate rollout of GEMS™ for Windows 7 remote ECG analysis, data management software to extensive base of current US health care providers and customers. TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) today announced that it has granted an aggregate of 500,060 incentive stock options. 250,060 options have been granted to Mr. Etienne Grima, the...

CardioComm Solutions to begin immediate rollout of GEMS™ for Windows 7 remote ECG analysis, data management software to extensive base of current US health care providers and customers. TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of electrocardiogram (“ECG”) acquisition and data management software solutions, is pleased to announce it will...

Licensing Deal Signals the Start of Sales of Windows 7 Compatible ECG Software Solutions TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) ("CardioComm Solutions" or the "Company") today announced that it has completed a software and source code licensing agreement ("SLA") for use of the Company's proprietary Global ECG Management Solution ("GEMS™") and GUAVA ECG viewer by MD Primer Inc. ("MDP"). MDP is a clinical research and education organization enabling...

HeartCheck™ Technologies to be used to identify people at risk for potentially life-threatening drug side effects TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) today announced that it has issued an aggregate of 58,141 common shares of the Company to Simi Grosman, a director of the Company. The shares were issued at a deemed price of $0.095 per share, for a total value of $5,500, as partial...

GUAVA II offers regulatory credibility and efficiency to ECG reading services for physicians and hospitals TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) ("CardioComm Solutions" or the "Company") a global medical provider of electrocardiogram (“ECG”) acquisition and management software solutions, confirms U.S. Food and Drug Administration (“FDA”) clearance of its GUAVA II ECG viewer technology as a Class II Medical Device. GUAVA II is the...

Arrhythmia Surveillance Utilized HeartCheck™ Device and SMART Monitoring ECG Service Technologies TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) ("CardioComm Solutions" or the "Company")today announced that it is working within a pilot that uses HeartCheck™ ECG testing technology to support arrhythmia screening and surveillance with long-term care facilities. The pilot was coordinated by Toronto-based In Initiative Inc. and conducted with Responsive...